Further Animal and Human Experience with a 0.6% Amino Acid/1.4% Glycerol Peritoneal Dialysis Solution

Vanholder R. , Lameire N. Osmotic agents in peritoneal dialysis; Kidney Int 1996; 50: S56, S86–91.

Lameire N. , Matthys D. , Matthys E. , Beheyt R. Effects of longterm CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30: S53–8.

Lameire N. Vanholder R, Vijt D, Lambert MC, Ringoir S. A longitudinal five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992; 42: 426–32.

Gokal R. , Ramos J.M. , MacGurk J.G. Hypertriglyceridemia in patients on CAPD. In: Gahl G.M. , Kessel M. , Nolph K.D. , eds Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1981; 430–3.

Lindholm B. , Bergstrom J. Nutritional aspects of peritoneal dialysis. In: Gokal R. , ed. Continuous ambulatory peritoneal dialysis. Edinburgh: Churchill Livingstone, 1986; 228–64.

Wheeler D. Abnormalities of lipoprotein metabolism in CAPD patients. Kidney Int 1996; 50: S41–6, S56.

Lameire N. , Vanholder R. , Van Loo A. , Lambert M.C. , Vijt D. , Ringoir S. Cardiovascular diseases in peritoneal dialysis patients: the size of the problem. Kidney Int 1996; 50: S28–36, S56.

Amann K. , Mandelbaum A. , Schwarz U. , Ritz E. Hypertension and left ventricular hypertrophy in the CAPD patient. Kidney Int 1996; 50: S37–40, S56.

Jörres A. , Topley N. , Gahl G.M. Biocompatibility of peritoneal dialysis fluids; Int JArtif Organs 1992; 15: 79–83.

Jorres A. , Topley N. , Witowski J. , Liberek T. , Gahl G.M. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1993; 13: S291–4.

Passlick-Deetjen J. The importance of biocompatibility in peritoneal dialysis solutions. Perit Dial Int 1993; 13: S101–4.

Goodship T. , Llyod S. , MacKenzie P. , Earnshaw M. , Smeaton I. , Wilkinson R. Short term studies on the use of amino acids as an osmotic agent in continuous peritoneal dialysis. Clin Sci 1987; 73: 471–8.

Lindholm B. , Werynski A. , Bergstrom J. Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics. Artif Organs 1988; 12: 2–10.

Lindholm B. , Park M. , Bergström J. Supplemented dialysis: Amino acid based solutions in peritoneal dialysis. Contrib Nephrol 1993; 103: 168–82.

Wolfe B. , Culebras J. , Sim A. , Moore F. Substrate interaction in intravenous feeding. Comparative effects of carbohydrate and fat on amino acid utilisation in fasting man. Ann Surg 1977; 186: 518–39.

Elwyn D. , Gump F. , Iles M. , Long C. , Kinney J. Protein and energy sparing of glucose added in hypocaloric amounts to peripheral infusions of amino acids. Metabolism 1978; 27: 325–31.

De Paepe M. , Matthys E. , Peluso F. , Dolkart R. , Lameire N. Experience with glycerol as the osmotic agent in peritoneal dialysis in diabetic and non-diabetic patients. In: Keen H. , Legrain M. , eds. Prevention and treatment of diabetic nephropathy. Lancaster: MTP Press, 1983; 299–313.

Matthys E. , Dolkart R. , Lameire N. Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Perit Dial Bull 1987; 7: 10–15.

De Paepe M. , Lameire N. Effects of glucose and glycerol on permeability of water and solutes in CAPD. In: Lameire N. , Ringoir S. , eds. The Proceedings of the fifth Benelux Symposium on CAPD, Ghent, 1986; 77–84.

Daniels F. , Leonard E. , Cortell S. Glucose and glycerol compared as osmotic agents for peritoneal dialysis. Kidney Int 1984; 25: 20–5.

Heaton A. , Ward M. , Johnston D. , Nicholson D. , Kerr D. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1984; 67: 121–30.

Matthys E. , Dolkart R. , Lameire N. Potential hazards of glycerol dialysate in diabetic patients. Perit Dial Bull 1987; 7: 16–9.

Lameire N. , Faict D. Peritoneal dialysis solutions containing glycerol and amino acids. Perit Dial Int 1994; 14: S145–51.

Faict D. , Lameire N. , Kesteloot D. , Peluso F. Evalution of peritoneal dialysis solutions with amino acids and glycerol in a rat model. Nephrol Dial Transplant 1991; 6: 120–4.

Dombros N. , Digenis G. , Oreopoulos D. Malnutrition in continuous ambulatory peritoneal dialysis. Contrib Nephrol 1992; 100: 188–206.

Faller B. Amino acid-based peritoneal dialysis solutions. Kidney Int 1996; 50(Suppl 56): S81–5.

Kopple J. , Bernard D. , Jones M. , Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47: 1148–57.

De Feyter C. , Verbrugh H. , Oe P. The effect of glycerol containing peritoneal dialysis fluid on peritoneal macrophage function in vivo. In: Khanna R. , Nolph K.D. , Pro want B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin 1991; 154–7.

Witowski J. , Knapowski J. , Glycerol toxicity for human peritoneal mesothelial cells in culture: Comparison with glucose. Int J Artif Organs 1994; 17: 252–60.

Breborowicz A. , Rodela H. , Oreopoulos D. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41: 1280–5.